Mana Capital Acquisition (MAAQ) Competitors $3.61 +0.01 (+0.28%) As of 07/1/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock MAAQ vs. PROC, CTNM, MIST, BYSI, HURA, COYA, CRBP, HLVX, IOBT, and OPTNShould you be buying Mana Capital Acquisition stock or one of its competitors? The main competitors of Mana Capital Acquisition include Procaps Group (PROC), Contineum Therapeutics (CTNM), Milestone Pharmaceuticals (MIST), BeyondSpring (BYSI), TuHURA Biosciences (HURA), Coya Therapeutics (COYA), Corbus Pharmaceuticals (CRBP), HilleVax (HLVX), IO Biotech (IOBT), and OptiNose (OPTN). These companies are all part of the "pharmaceutical products" industry. Mana Capital Acquisition vs. Its Competitors Procaps Group Contineum Therapeutics Milestone Pharmaceuticals BeyondSpring TuHURA Biosciences Coya Therapeutics Corbus Pharmaceuticals HilleVax IO Biotech OptiNose Mana Capital Acquisition (NASDAQ:MAAQ) and Procaps Group (NASDAQ:PROC) are both small-cap pharmaceutical products companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, earnings, valuation, institutional ownership, profitability, analyst recommendations and media sentiment. Is MAAQ or PROC more profitable? Company Net Margins Return on Equity Return on Assets Mana Capital AcquisitionN/A N/A N/A Procaps Group N/A N/A N/A Do institutionals & insiders believe in MAAQ or PROC? 68.4% of Mana Capital Acquisition shares are held by institutional investors. 19.9% of Procaps Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer MAAQ or PROC? In the previous week, Mana Capital Acquisition's average media sentiment score of 0.00 equaled Procaps Group'saverage media sentiment score. Company Overall Sentiment Mana Capital Acquisition Neutral Procaps Group Neutral Which has preferable earnings & valuation, MAAQ or PROC? Procaps Group has higher revenue and earnings than Mana Capital Acquisition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMana Capital AcquisitionN/AN/AN/AN/AN/AProcaps Group$409.92M0.26$42.54MN/AN/A SummaryProcaps Group beats Mana Capital Acquisition on 2 of the 3 factors compared between the two stocks. Get Mana Capital Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for MAAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MAAQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MAAQ vs. The Competition Export to ExcelMetricMana Capital AcquisitionIn Vitro, In Vivo Diagnostic Substances IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$29.33M$29.33M$2.23B$9.00BDividend YieldN/AN/A2.63%4.10%P/E RatioN/AN/A22.9820.02Price / SalesN/AN/A51.93120.95Price / CashN/AN/AN/A56.90Price / BookN/AN/A106.515.50Net IncomeN/AN/A-$241.20M$248.50M7 Day Performance3.14%3.14%1.03%2.61%1 Month Performance-15.06%-15.06%3.37%5.42%1 Year Performance568.39%568.39%23.64%20.76% Mana Capital Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MAAQMana Capital AcquisitionN/A$3.61+0.3%N/A+556.4%$29.33MN/A0.001Gap UpPROCProcaps GroupN/A$0.95-40.3%N/A-62.0%$107.18M$409.92M0.004,900Gap DownHigh Trading VolumeCTNMContineum Therapeutics2.0141 of 5 stars$4.11+2.5%$22.50+447.4%-80.7%$103.75M$50M-2.0931High Trading VolumeMISTMilestone Pharmaceuticals2.6974 of 5 stars$1.86-4.1%$7.00+276.3%+42.2%$103.72M$1M-2.3830News CoveragePositive NewsBYSIBeyondSpringN/A$2.45-2.8%N/A-3.0%$101.60M$1.75M0.0080HURATuHURA Biosciences1.501 of 5 stars$2.22-3.1%$12.67+470.6%N/A$100.03MN/A0.00N/AAnalyst RevisionGap UpHigh Trading VolumeCOYACoya Therapeutics2.3025 of 5 stars$5.85-0.8%$16.67+184.9%-4.5%$98.68M$3.55M-5.476Analyst ForecastCRBPCorbus Pharmaceuticals3.9189 of 5 stars$7.40-7.7%$50.88+587.5%-83.9%$98.14MN/A-1.7540High Trading VolumeHLVXHilleVax3.285 of 5 stars$1.97+1.0%$3.00+52.3%-85.2%$97.78MN/A-0.9220High Trading VolumeIOBTIO Biotech3.1081 of 5 stars$1.44-2.7%$9.33+548.1%+26.3%$97.50MN/A-1.0530Gap UpOPTNOptiNose0.6866 of 5 stars$9.60flat$9.00-6.3%N/A$97.22M$81.86M-2.29190 Related Companies and Tools Related Companies PROC Alternatives CTNM Alternatives MIST Alternatives BYSI Alternatives HURA Alternatives COYA Alternatives CRBP Alternatives HLVX Alternatives IOBT Alternatives OPTN Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MAAQ) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mana Capital Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mana Capital Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MAAQ Stock Alerts